172.72MMarket Cap-8038P/E (TTM)
2.120High2.050Low210.19KVolume2.070Open2.100Pre Close436.05KTurnover0.38%Turnover RatioLossP/E (Static)82.64MShares3.29052wk High11.88P/B117.07MFloat Cap1.33052wk Low--Dividend TTM56.01MShs Float10.300Historical High--Div YieldTTM3.33%Amplitude1.330Historical Low2.074Avg Price1Lot Size
Stereotaxis Stock Forum
NEWS
Stereotaxis Reports 2024 First Quarter Financial Results
Stereotaxis (NYSE: STXS), a leader in surgical robotics for minimally invasive endovascular intervention, reported financial results for Q1 2024, ending March 31. Revenue grew 5% YoY to $6.9M, with system revenue at $2.6M and recurring revenue at $4.3M. Gross margin was 58%. Operating expenses were $8.7M, including $2.6M in non-cash stock compensation. Adjusted operating expenses were $6.1M, down from $6.9M YoY....
NEWS
Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies
Stereotaxis (NYSE: STXS), a leader in surgical robotics for minimally invasive endovascular intervention, announced a definitive agreement to acquire Access Point Technologies EP (APT). APT, based in Minnesota, develops electrophysiology catheters used in cardiac ablation procedures. This acquisition enhances Stereotaxis' catheter development, manufacturing capabilities, and provides comme...
MBOT MVST AVRO HTCR MVLA KC STXS PACW
$Microbot Medical(MBOT.US)$ $Microvast(MVST.US)$ $Avrobio(AVRO.US)$ $HeartCore Enterprises(HTCR.US)$ $Movella Holdings(MVLA.US)$ $Kingsoft Cloud(KC.US)$ $Stereotaxis(STXS.US)$ $PacWest Bancorp(PACW.US)$
No comment yet